Sponsor:
Sabine Mueller, MD, PhD
Code:
NCT04323046
Conditions
Glioblastoma
Malignant Glioma
Recurrent Glioblastoma
Recurrent Malignant Glioma
Recurrent Grade III Glioma
Eligibility Criteria
Sex: All
Age: 6 - 25
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Quality-of-Life Assessment
Questionnaire Administration
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Sabine Mueller, MD, PhD on 2025-04-23.